SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Shares of Celsius Holdings are trending as traders react to an insider purchase by CEO John Fieldly, with community sentiment divided between those viewing the move as a bullish signal and others expressing disappointment in the size of the acquisition while renewing calls for management changes.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ remains a focal point of intense debate as investors weigh strong corporate earnings against a precarious macro environment marked by surging oil prices and rising Treasury yields. Market sentiment remains fractured, with traders divided between anticipating a potential volatility event and relying on historical resilience to power through looming inflationary data.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro is trending as investors monitor the company's progress in scaling its proprietary Hydrochemolytic technology, with recent focus on its expanded partnership with ECOCE in Mexico and a new memorandum of understanding for synthetic turf recycling. While supporters highlight long-term potential in circular economy markets and institutional accumulation, critics remain skeptical, citing a lack of demonstrated commercial profitability after several years of development.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is debating the rapid collapse of the newly launched meme coin, with many traders labeling the event as a significant rug pull that caused immediate, substantial losses. Participants are expressing widespread skepticism and mocking the speculative nature of the project.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares gained momentum after reporting first-quarter results that exceeded earnings and revenue expectations, driven by triple-digit growth in cloud infrastructure and a record $664 billion backlog of AI cloud contracts. While sentiment is overwhelmingly bullish regarding the company's long-term AI-driven expansion, some traders remain cautious due to negative free cash flow, significant capital expenditure requirements, and macroeconomic uncertainty surrounding upcoming inflation data.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The community is primarily focused on market anxiety driven by surging Treasury yields approaching 5%, rising oil prices due to Middle East tensions, and higher-than-expected producer inflation data. Traders are debating whether these factors will force the Federal Reserve to hike interest rates at the upcoming meeting, with many expressing skepticism toward the current market resilience.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as oil prices climb amid heightened geopolitical tensions in the Middle East and reports of disrupted energy infrastructure. Traders are debating whether to maintain bullish positions or short the ETF, with some citing economic risks from potential inflation and Federal Reserve policy shifts, while others highlight the impact of the ongoing conflict on supply.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

The community is engaged in a debate over the role of precious metals amid rising U.S. yields and concerns over fiscal dominance and currency debasement. While some traders view the recent price action as a buying opportunity, others remain cautious, highlighting the inverse correlation between gold and interest rates as a primary focus.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors react to a significant volume of insider buying by co-CEOs, totaling approximately $100 million in open-market purchases. The community is focused on the potential for the company's ivonescimab to challenge existing standard-of-care treatments, with bullish sentiment largely driven by upcoming clinical data and the November PDUFA date for FDA review.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

The community conversation is fragmented, with traders debating the potential impact of the Clarity Act on future regulation and discussing speculative price movements alongside broader institutional adoption and infrastructure developments. While some express optimism about long-term potential, others remain skeptical, citing concerns about token dilution and market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine, and Biogen Inc. (Nasdaq: BIIB) today announced presentations of data at the 16th European Epilepsy Congress (EEC), taking place September...

Stoke Therapeutics to Present at the Cantor Global Healthcare Conference

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet...

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Stoke Therapeutics (STOK) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference

These Analysts Revise Their Forecasts On Stoke Therapeutics After Q2 Results

Stoke Therapeutics (STOK) reported mixed Q2 results with losses of 93 cents per share and sales of $9.325 million. Analysts have mixed opinions.read more...

Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates

Stoke Therapeutics (STOK) delivered earnings and revenue surprises of -13.42% and +69.55%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Stoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates

Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2026 Business and Financial Updates

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Stoke Therapeutics Inc

Neutral Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$29.34
Prev Close	$29.92
Open	$29.62
Dividend Yield	0.00%
50-Day Moving Average	$31.00
Beta	1.26
Avg. Volume	993,292.11
PE Ratio	-8.70

52-Week High	$40.22
52-Week Low	$20.32
Market Capitalization	$1.93B
EPS (Annual)	-$0.1163
Price to Book	5.30
Revenue Per Employee	$1.08M

Feed

News

Sentiment

Earnings

Fundamentals

Info

STOK Fundamentals